Log in
Enquire now
Innovent Biologics

Innovent Biologics

Innovent Biologics is a monoclonal Antibodies, Biosimilars founded in 2011.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
0
CEO
Michael Yu
Michael Yu
Company Operating Status
Active
Strategic Partnerships
Incyte
Incyte
Country
China
China
Crunchbase URL
crunchbase.com/organiz...iologics
Facebook URL
@innovent2011
Founded Date
2011
Headquarters
Jiangsu
Jiangsu
Industry
Biology
Biology
Engineering
Engineering
Biosimilar
Biosimilar
Research and development
Research and development
Biomedical engineering
Biomedical engineering
Technology
Technology
Biotechnology
Biotechnology
Invested in
AnHeart Therapeutics
AnHeart Therapeutics
0
Investors
Frontline BioVentures
Frontline BioVentures
Rock Springs Capital
Rock Springs Capital
Hillhouse Capital Group
Hillhouse Capital Group
Temasek Holdings
Temasek Holdings
‌
Taikang Life Insurance
Legend Capital
Legend Capital
Lilly Asia Ventures
Lilly Asia Ventures
‌
Fidelity Growth Partners Asia
‌
Fidelity Biosciences
Cormorant Asset Management
Cormorant Asset Management
•••
Latest Funding Round Date
April 2018
Latest Funding Type
Series E
Series E
LinkedIn URL
@company/innovent-biologics-inc-
Location
Jiangsu
Jiangsu
United Kingdom
United Kingdom
Suzhou
Suzhou
China
China
Number of Employees (Ranges)
5,001 – 10,000
0
Patents Assigned (Count)
3
Place of Incorporation
Cayman Islands
Cayman Islands
Exchange
Hong Kong Stock Exchange
Hong Kong Stock Exchange
Stock Symbol
1801.HK
Total Funding Amount (USD)
375,000,000
Twitter URL
@Innovent_2011
Official Website
innoventbio.com
cn.innoventbio.com
innoventbio.com/en

Find more companies like Innovent Biologics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.